(Q48611873)

13 February 2018

reason for preferred rank

title

(+)- and (−)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

5 August 2023

(+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099268

5 August 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

5 August 2023

author name string

D. Clark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099268

5 August 2023

S. Hjorth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099268

5 August 2023

A. Carlsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099268

5 August 2023

language of work or name

English

0 references

publication date

1 October 1984

1 reference

13 February 2018

30 October 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6099268

full work available at URL

5 August 2023

https://api.elsevier.com/content/article/PII:0014299984906940?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

https://api.elsevier.com/content/article/PII:0014299984906940?httpAccept=text/plain

5 August 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

European Journal of Pharmacology

5 August 2023

published in

1 reference

13 February 2018

volume

106

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

185-189

1 reference

13 February 2018

Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

Dopamine receptor agonists: intrinsic activity vs. state of receptor

5 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.

5 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

5 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.

5 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

In vitro effect of the racemic mixture and the (-)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor

5 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

5 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90694-0

5 August 2023

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018